Diseases, Conditions, Syndromes

More drugs show promise in fighting hepatitis C

(HealthDay)—An experimental drug duo may cure some cases of the liver disease hepatitis C, without the severe side effects of standard therapy, a new clinical trial suggests.

Diseases, Conditions, Syndromes

Hepatitis B: What people can learn from donkeys

The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that the course of the infection ...

Oncology & Cancer

Many hepatitis infections go undiagnosed in cancer patients

Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but treatable ...

Diseases, Conditions, Syndromes

How hepatitis C virus evades the immune system

Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect the host chronically is not entirely understood. ...

Diseases, Conditions, Syndromes

Danger signal limits Hepatitis C infection

Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...

Diseases, Conditions, Syndromes

The economic cost of advanced liver disease

Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study.

page 5 from 18